From: Tracking tDCS induced grey matter changes in episodic migraine: a randomized controlled trial
 | tDCS (N = 11) | Sham (N = 13) | p value |
---|---|---|---|
Age, years | 41.0 ± 14.8 | 35.1 ± 9.7 | 0.251 |
Female Sex, no. (%) | 10 (90.9) | 13 (100) | 0.458 |
Average number of migraine days during baseline period | 4.7 ± 2.2 | 6.4 ± 2.7 | 0.118 |
Average migraine intensity during baseline period | 6.3 ± 1.2 | 5.4 ± 1.8 | 0.199 |
Disease duration, years | 22.0 ± 12.4 | 18.5 ± 11.6 | 0.546 |
Aura, no. (%) | 7 (63.6) | 8 (61.5) | 1.000 |
Number of stimulation days | 30.1 ± 2.9 | 28.8 ± 1.9 | 0.147 |
HADS-D score during baseline period | 3.8 ± 2.2 | 4.1 ± 3.4 | 0.829 |
FUP1, days | 48.7 ± 6.9 | 50.2 ± 8.5 | 0.644 |
FUP2, days | 161.5 ± 52.5 | 174.2 ± 69.5 | 0.352 |